Background. Sepsis is an important cause of mortality among older adults in the United States. The association between sepsis and subsequent risk of cancer is poorly understood.
Sepsis is a leading cause of death in the United States, with an incidence of approximately 300 per 100 000 person-years [1] . More than half of sepsis cases occur in adults aged >65 years [2] . Infection with bacteria is the major causes of sepsis [3] . Important risk factors include advanced age, low socioeconomic status, obesity, the presence of chronic health conditions (including chronic obstructive pulmonary disease, cancer, renal or liver disease, and diabetes mellitus), and compromised immune function due to human immunodeficiency virus (HIV) infection or use of immunosuppressive medications [3] .
Mortality from sepsis has declined over the past 2 decades, partly due to advances in supportive care [4] . Recent studies have described long-term consequences in sepsis survivors, including cognitive and functional impairments, sustained inflammation, and immune dysfunction [5, 6] . This evidence challenges the notion that sepsis is only an acute, transient illness, revealing instead that there is a constellation of persisting health outcomes [7] . Although sepsis alone may not cause cancer, it is possible that underlying medical conditions that predispose to sepsis, the health consequences of sepsis, and the treatment of sepsis could be associated with cancer development through a range of mechanisms [8, 9] . However, the association between sepsis and subsequent risk of cancer has not been evaluated.
Both sepsis and cancer disproportionately affect older adults [10] . In the present study, we use a large, nationally representative database of elderly individuals in the United States, the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database [11] [12] [13] , to systematically investigate associations between sepsis and subsequent risk of cancer. Our study is exploratory and aimed at generating hypotheses.
METHODS

Data Source
SEER-Medicare is an electronic linkage of SEER and Medicare databases [11, 12] . Briefly, SEER is a cancer surveillance program of the National Cancer Institute with information on demographics and tumor characteristics from 18 cancer registries that cover approximately 28% of the US population [13] . Medicare is a federally funded program that provides health insurance to approximately 97% of the US elderly (aged ≥65 years). All Medicare-eligible individuals are entitled to part A coverage (for hospital inpatient care), and approximately 96% subscribe to part B (physician and outpatient care). Beneficiaries can elect to enroll in a health maintenance organization (HMO); Medicare does not receive claims for individual medical conditions for HMO enrollees. SEER-Medicare includes claims data for SEER cancer cases and a 5% random sample of Medicare beneficiaries residing in SEER geographic areas.
This research was not considered human subjects research by the National Institutes of Health and therefore was exempted from human subjects review.
Study Design and Study Population
We conducted a population-based case-control study using the SEER-Medicare database [12] . Eligible cases comprised people with a first cancer diagnosis identified in SEER during 1992-2013 at ages 66-115 years. In ascertaining sepsis before cancer diagnosis, we excluded the 1-year period prior to cancer diagnosis to minimize the possibility of reverse causation (ie, incipient cancer leading to sepsis). Therefore, we required that cases had ≥13 months of Medicare part A, part B, non-HMO coverage before cancer diagnosis (exclusion of 1 year of data allowed assessment of at least 1 month of claims). We estimate that about 20%-25% of Medicare beneficiaries enrolled in HMOs were excluded due to no information on specific medical conditions or healthcare. We also excluded cases diagnosed only at autopsy or on death certificates. We categorized cancer cases using a modified version of the SEER site recode and histologic subtypes for some cancers using International Classification of Diseases for Oncology, version 3, morphology codes [14] .
We randomly selected 200 000 population-based controls from the 5% random sample of Medicare beneficiaries. Controls were frequency-matched to cases by calendar year of selection, age, sex, and race/ethnicity (Table 1) and were required to be alive and cancer free as of 1 July of the selection year [12] . Controls were sampled only once in a calendar year but could be sampled repeatedly across calendar years and also become cases. As for the cases, controls were required to have at least 13 months of part A, part B, non-HMO Medicare coverage prior to selection.
Ascertainment of Sepsis and Covariates
We used International Classification of Diseases, 9th edition (ICD-9), diagnosis codes to define sepsis and covariates. In our main analysis, we identified sepsis by ICD-9 codes using the Angus algorithm, which has been widely used and clinically validated [1] . This algorithm requires the presence of diagnosis codes for either severe sepsis (995.92) or septic shock (785.52) or for both acute organ dysfunction and infection (see Supplementary Table 1 for ICD-9 codes). The sensitivity, specificity, positive predictive value (PPV), and negative predictive value of this definition compared to medical record abstraction are 50.3%, 96.3%, 70.7%, and 91.5%, respectively [15] . Individuals with an inpatient claim that met the Angus definition, excluding the 1-year period before cancer diagnosis/ control selection, were considered to have sepsis. In a sensitivity analysis, we used an alternative definition, requiring a diagnosis code for sepsis only (ICD-9 codes 995.92 or 785.52), which has a higher specificity (100%) and PPV (100%) but lower sensitivity (9.3%) than the Angus algorithm [15] .
Because HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection; smoking; alcohol abuse; cirrhosis; diabetes mellitus; and selected autoimmune diseases may be associated with both sepsis and certain cancers, we identified individuals who had at least 1 Medicare claim for these conditions before 1 year prior to cancer diagnosis/control selection (Supplementary Table 1 ). We also assessed socioeconomic status as indicated by the median household income of the person's residential zip code and healthcare utilization as determined by the number of physician claims per year (excluding Table 2 ).
Statistical Analyses
To select cancer sites for investigation, we calculated the expected number of cases with sepsis by multiplying the number of cancer cases by the prevalence of sepsis in our controls (3.7%). We included cancers where the expected number of cases with sepsis was >50. Thus, we assessed 42 cancer types and had at least 80% power to detect an odds ratio (OR) as low as 1.6 for the least frequent cancers, after correcting the P values for multiple testing (Bonferroni significance level 0.001 = 0.05/42). We used multivariate unconditional logistic regression to estimate ORs for the association of sepsis with cancer overall and individual types. The variances of ORs obtained were adjusted for repeated selection of some controls across calendar years and inclusion of some controls who later became cases [12] . The minimally adjusted model included the matching variables (sex, age, race/ethnicity, and calendar year of case/ control selection), number of physician visits per year, smoking status, and history of alcohol abuse. Although we present 95% confidence intervals (CIs), we considered associations with P value < .001 as noteworthy.
Associations with sepsis that were significant after Bonferroni correction were further assessed by latency, ie, time from the first sepsis diagnosis to cancer diagnosis/control selection (1-2, >2-5, >5 years). We focused on cancers with significant associations (P value < .05) for the longest latency period (>5 years), because these long-term associations would be least likely confounded by artifacts related to differences in medical evaluations or cancer screening between sepsis survivors and other individuals. For these cancers, we additionally adjusted for potential confounders based on our prior knowledge related to HIV, HBV, and HCV infections; diabetes; autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, Addison's disease, Crohn's disease, psoriasis, ulcerative colitis, and giant cell arteritis); and cirrhosis (for associations with liver cancer).
In a sensitivity analysis, we reanalyzed the data by adjusting for median household income. To rule out residual confounding due to HIV, HBV, or HCV infections (which could not be entirely captured by Medicare claims), we performed a subgroup analysis limited to study participants without any record of these infections. We also analyzed the data using the more stringent definition of sepsis.
Finally, to explore the potential role of cancer screening for 3 cancers significantly associated with sepsis in the period >5 years following sepsis diagnosis (colon, rectal, and prostate cancers), we further calculated ORs overall and by SEER historic
year). Statistical analyses were performed using SAS, version 9.4 (SAS Institute, Cary, NC).
RESULTS
A total of 1 801 156 cancer cases and 200 000 cancer-free controls were included (Table 1) . By design, cases and controls were perfectly frequency-matched on sex, age, calendar year of diagnosis/selection, and race/ethnicity. Cases had a similar number of physician claims per year as controls. Although differences were small, cases were more likely to be smokers or alcohol abusers and to have HBV infection, HCV infection, diabetes mellitus, autoimmune disease, or cirrhosis.
The prevalence of sepsis appeared to be slightly higher among cases than controls (4.0% vs 3.7%), but the association with cancer overall was not significant (minimally adjusted OR = 1.01; 95% CI, 0.98-1.04; Figure 1 ). After correction for multiple comparisons, we observed significant associations between sepsis and risk of 15 cancers (Figure 1 ). Positive associations were observed for cancers of the colon (minimally adjusted OR = 1.12; 95% CI, 1.08-1. In analyses stratified by time intervals between sepsis diagnosis and cancer diagnosis/control selection (Figure 2) , sepsis was significantly associated with the following 9 cancers in the period >5 years following sepsis diagnosis: cancers of thyroid, prostate, colon, rectum, lung, and liver as well as follicular lymphoma, melanoma, and AML (all P values < .05). Further adjustment for other potential confounders did not meaningfully change the results (Supplementary Table 3 ), although risk for liver cancer was attenuated (fully adjusted OR = 1.17; 95% CI, 1.08-1.27).
Results from the sensitivity analyses for these 9 cancers are shown in Supplementary Table 4 . The magnitude of the associations remained similar when models were additionally adjusted for socioeconomic status or when individuals infected with HIV, HBV, or HCV were excluded. When we used the more stringent criterion for sepsis diagnosis, we no longer observed statistically significant associations for cancers of liver and rectum, as well as AML. However, the magnitudes of associations for most cancers were maintained, except for liver cancer where the strength of association was attenuated.
For colorectal cancer, associations with sepsis were virtually unchanged when history of screening was included in the model, compared to the estimates obtained from the minimally adjusted models (Table 2) . Evaluation by cancer stage showed that ORs for colorectal cancer were consistently elevated, although sepsis appeared to have a stronger association with distant stage (OR for colon cancer, 1.15; OR for rectal cancer, 1.12) than local/regional stage (colon cancer, 1.03; rectal cancer, 1.09). In addition, the risk for local/regional prostate cancer was decreased (OR = 0.76; 95% CI, 0.72-0.79), while an increased risk for distant prostate cancer was observed (1.15, 1.05-1.26).
DISCUSSION
To the best of our knowledge, this is the first study to evaluate the association between sepsis and subsequent risk of cancer. We observed that sepsis is significantly associated with 15 cancers among elderly adults in the United States. Sepsis remained significantly associated with a diverse group of 9 cancers in the period >5 years following a sepsis diagnosis, and the associations indicated both increased and decreased risks.
The elevated risks seen for cancers of the lung, colon, rectum, and liver are consistent with a possible carcinogenic role of bacterial infections in these cancers. For example, although uncommon, severe sepsis due to pulmonary infection with Chlamydia pneumoniae has been reported [16] . Chlamydia pneumoniae has been linked to an increased risk of lung cancer in a series of epidemiologic studies [17, 18] , and respiratory infection may act synergistically with carcinogens in tobacco smoke to cause lung damage [18] . Alternatively, sepsis could serve as an indicator of the presence of precancerous conditions Figure 2 . Associations between sepsis and risk of selected cancer according to time intervals between sepsis diagnosis and cancer diagnosis/control selection. The associations with sepsis are presented for each cancer that was significantly associated with sepsis in the minimally adjusted analysis (Figure 1 ). For each time interval (1-2, 3-5, >5 years), we depict the odds ratio (OR) and corresponding 95% confidence interval (horizontal axis, logarithmic scale), adjusted for the matching variables (sex, age group [66-69, 70-74, 75-79, 80-84, 85-115 years], calendar year of case/control selection, and race/ethnicity), number of physician visit claims per year (excluding the 12 months prior to selection), smoking status, and history of alcohol abuse. The cancers are ordered by the OR for >5 years since sepsis diagnosis. Asterisk indicates cancers that had a significant association with sepsis in the period >5 years since sepsis diagnosis (P value < .05). Abbreviations: AML, acute myeloid leukemia; CI, confidence interval; CML, chronic myeloid leukemia; DLBCL, diffuse large B-cell lymphoma; MDS, myelodysplastic syndrome; OR, odds ratio.
rather than itself play a causal role in cancer development. For example, infections with Enterobacteriaceae are very common in patients with cirrhosis (an important predisposing factor for liver cancer) [19] , and patients with Streptococcus gallolyticus bacteremia, endocarditis, or sepsis frequently have precancerous colorectal polyps [20, 21] .
Risk was also increased for myeloid leukemias (ie, AML, CML, and MDS) without established links to infections. One possibility is that inflammation induced by sepsis may contribute to the development of leukemias [22] , as suggested by studies showing increased risk of leukemia in individuals with autoimmune diseases [23, 24] . Furthermore, a lower risk of leukemia in association with use of nonsteroidal antiinflammatory drugs (NSAIDs) has been consistently reported [25] [26] [27] , and NSAIDs appear capable of inducing apoptosis in AML cells [28, 29] . The disturbed balance between the proinflammatory and antiinflammatory response may lead to overproduction of several cytokines [30] , which appear to play a role in the etiology of leukemias [22] .
Another alternative explanation is that these associations reflect an underlying abnormal immune state that predisposes to both sepsis and leukemia [5, 24] . Risk for myeloid leukemias is elevated in individuals with other immunosuppressive conditions such as HIV infection or solid organ transplantation [31] [32] [33] . However, we did not observe associations between sepsis and some virus-related malignances (eg, DLBCL and anal cancer) that are strongly increased in HIV-infected people and transplant recipients [31] [32] [33] . In fact, risk for DLBCL and follicular lymphoma were decreased among individuals with sepsis.
We observed decreased risks for cancers of the breast, prostate, kidney, and thyroid, as well as melanoma. The decreased risks are mirrored by decreased risks observed in people with HIV infection in some studies [32, 33] , although the explanation for such decreases remains obscure. Some deficits may reflect underdetermination or decreased rates of cancer screening in patients with a history of sepsis. This pattern of strongest association in the initial intervals after sepsis diagnosis (ie, breast and kidney cancers) could arise if patients with a recent sepsis diagnosis, due to the presence of multiple medical comorbidities or frailty, were not offered breast cancer screening or evaluated for possible early signs of cancer (eg, weight loss, hematuria). Likewise, the reduced risk observed for prostate cancer could reflect an artifact of decreased screening, which is supported by the fact that the decreased risks were attenuated as the time interval following sepsis diagnosis increased. In addition, the deficit was observed only for prostate cancer with local/regional stage (which is largely detected through screening), and there was actually an increased risk of distant stage prostate cancer.
Finally, some associations between sepsis and cancer may be due to the use of antibiotics to treat sepsis. The lower risk of non-Hodgkin lymphoma (NHL) in sepsis patients in our study is consistent with the findings of Anderson et al, in which nonsignificant lower risk of NHL was observed among antibiotic users [34] , although 2 other studies found no association [8, 35] . By contrast, antibiotic use has been associated with increased risks of cancers in lung, colon, rectum, and liver [8, 9, 36, 37] . Potential explanations include the carcinogenicity of antibiotics, disturbance of the microbiome, and detrimental effects on immune defense [38] [39] [40] .
Strengths of the present study include its large sample size and population-based design. We comprehensively evaluated associations with 42 cancers and performed analyses according to latency interval and cancer stage. Nonetheless, our study has a few limitations. First, our results are not directly generalizable to a younger population because our study included only elderly individuals. However, because incidences of both sepsis and most cancers increase with age, the elderly are an important group in whom to assess these associations. Second, we were unable to completely assess several confounding factors. For instance, some medical comorbidities may predispose to both sepsis and cancer. However, it is also possible that sepsis may cause cancer by causing the same comorbidities (ie, mediation), in which case one would not want to adjust for those comorbidities. It also seems difficult to distinguish the possible effects of sepsis from those of localized infections (eg, pneumonia) that cause sepsis. Although we evaluated smoking, alcohol use, and viral infections using Medicare claims, these conditions are incompletely captured, so residual confounding was possible even after our adjustment. Third, we identified sepsis using administrative claims, and misclassification cannot be ruled out. It is possible that sepsis is overdiagnosed due to the need for reimbursement. The diagnostic accuracy of the coding system we used has been assessed against clinical and physiologic criteria [15] . We used the previously validated Angus algorithm to identify patients with sepsis [1, 15] , and results were similar using an alternative approach. However, both methods likely miss cases with less severe organ dysfunction. Fourth, Medicare claims lacked data on specific treatments (eg, different antibiotic drugs), so we could not assess their impact on cancer risk. Finally, given the large number of cancers that were evaluated, false-positive findings cannot be ruled out.
In conclusion, sepsis is associated with increased or decreased risk for a small group of cancers among elderly US adults. Sepsis may not be causally associated with these cancers, and multiple factors may contribute to these associations, including etiologic effects of bacterial infections, inflammation, or use of antibiotics. Other associations may reflect the presence of precursor conditions (eg, cirrhosis, colorectal polyps) or patterns in ascertainment of cancer and screening. Further studies are needed to replicate our findings and explore the underlying mechanisms. Our data also support the notion that sepsis is an acute illness that can have important long-term health consequences, although the modest magnitude of these associations likely does not support close cancer surveillance of sepsis survivors.
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